![](/img/cover-not-exists.png)
Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group
V. Urosevic, Ph. Chollet, A. Adenis, J. Chauvergne, P. Fargeot, H. Roche, P. Kerbrat, M.A. Lentz, P. Fumoleau, B. ChevallierVolume:
32
Year:
1996
Language:
english
Pages:
183
DOI:
10.1016/0959-8049(95)00473-4
File:
PDF, 279 KB
english, 1996